v3.25.2
Product Sales year-on-year analysis: H1 2025 (Tables)
6 Months Ended
Jun. 30, 2025
Product Sales year-on-year analysis: H1 2025  
Product Sales year-on-year analysis: H1 2025

World

US

Emerging Markets

Europe

Established RoW

For the half year ended 30 June

Change

Change

Change

Change

Change

    

$m

    

Act %

    

CER %

    

$m

    

Act %

    

$m

    

Act %

    

CER %

    

$m

    

Act %

    

CER %

    

$m

    

Act %

    

CER %

Tagrisso

 

3,488

9

10

1,439

12

1,008

10

13

658

5

5

383

3

3

Imfinzi

 

2,716

20

21

1,572

31

294

20

28

537

17

17

313

(11)

(11)

Calquence

1,634

8

9

1,090

4

103

36

49

368

15

15

73

12

15

Lynparza

1,564

8

9

689

14

323

1

4

425

7

6

127

1

2

Enhertu

428

72

76

292

82

88

94

65

63

42

35

41

Zoladex

567

3

6

9

16

442

7

10

72

(7)

(8)

44

(10)

(9)

Truqap

302

n/m

n/m

253

80

8

n/m

n/m

28

n/m

n/m

13

n/m

n/m

Imjudo

170

25

25

111

26

12

58

68

23

43

43

24

(1)

(2)

Other Oncology

 

216

(10)

(8)

4

(63)

146

(7)

(5)

10

(16)

(16)

56

(6)

(7)

Oncology

 

11,085

14

15

5,167

18

2,628

14

19

2,215

13

12

1,075

(1)

Farxiga

4,206

11

13

803

(7)

1,730

17

23

1,448

17

17

225

7

7

Crestor

635

8

10

24

11

547

15

17

n/m

n/m

64

(9)

(8)

Brilinta

520

(22)

(21)

271

(23)

137

(18)

(16)

107

(21)

(21)

5

(39)

(34)

Seloken

 

308

(2)

2

n/m

298

(3)

1

8

34

38

2

(9)

(5)

Lokelma

 

328

31

32

144

25

63

50

54

56

36

36

65

27

26

roxadustat

 

150

(8)

(7)

150

(8)

(7)

Wainua

84

n/m

n/m

82

n/m

1

1

Other CVRM

 

274

(27)

(26)

27

(74)

138

14

16

76

(37)

(37)

33

7

7

CVRM

 

6,505

6

7

1,351

(9)

3,064

11

15

1,696

9

9

394

6

6

Symbicort

 

1,438

(4)

(2)

598

400

(11)

(8)

272

(5)

(5)

168

7

10

Fasenra

 

920

18

18

556

16

52

26

32

229

19

19

83

19

20

Breztri

583

28

29

295

31

156

19

21

87

34

34

45

34

36

Tezspire

198

99

n/m

16

n/m

n/m

128

n/m

n/m

54

61

63

Pulmicort

264

(30)

(28)

4

(57)

208

(34)

(32)

34

(8)

(7)

18

8

11

Saphnelo

304

49

49

265

44

7

n/m

n/m

21

n/m

n/m

11

45

45

Airsupra

 

70

n/m

n/m

69

n/m

1

n/m

n/m

Other R&I

 

158

(8)

(8)

55

4

70

(18)

(17)

29

(2)

(3)

4

(4)

R&I

 

3,935

9

10

1,842

18

910

(12)

(9)

800

18

17

383

19

21

Beyfortus

128

n/m

n/m

102

91

24

n/m

n/m

2

n/m

n/m

Synagis

162

(36)

(33)

(1)

(22)

121

(8)

(3)

25

(62)

(60)

17

(70)

(71)

FluMist

10

20

16

n/m

n/m

n/m

n/m

n/m

10

n/m

n/m

Other V&I

1

(91)

(91)

n/m

n/m

1

(91)

(91)

n/m

n/m

V&I

 

301

(7)

(5)

101

82

121

(7)

(3)

50

(39)

37

29

(49)

(50)

Ultomiris

 

2,228

23

24

1,272

23

113

71

82

498

21

21

345

17

17

Soliris

974

(32)

(30)

568

(30)

224

(12)

(1)

112

(57)

(57)

70

(40)

(38)

Strensiq

746

14

15

584

10

50

61

67

57

19

20

55

24

23

Koselugo

 

275

11

13

106

5

76

(9)

(5)

71

58

58

22

25

25

Other Rare Disease

113

12

14

54

16

20

4

16

34

12

12

5

9

10

Rare Disease

4,336

2

3

2,584

3

483

6

16

772

(3)

(3)

497

4

4

Nexium

426

(7)

(5)

37

(21)

333

5

8

17

(35)

(35)

39

(43)

(41)

Other

82

(19)

(18)

3

(46)

59

(12)

(11)

18

(32)

(33)

2

8

7

Other Medicines

508

(9)

(7)

40

(23)

392

2

4

35

(34)

(34)

41

(41)

(40)

Total Medicines

 

26,670

8

10

11,085

10

7,598

8

12

5,568

8

8

2,419

2

2